Updates in Fecal Microbiota Transplantation

UCSF School of Medicine

M. Brondfield

Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Neuromodulators: Making the Right Choice for Your Patient

Douglas Drossman

Embracing Aging: Helping Our Loved Ones, Helping Ourselves

Pacific Neuroscience Institute

S. Kaiser, A. Effinger

Cognitive Disorders

ZINCARE

M. Mataa

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Detection and Management of Hepatic Encephalopathy

Michigan Medicine

P. Bloom

2022 Updates on the Management of Lupus Nephritis

West Virginia State Rheumatology Society

M. Petri

Aducanumab: What Neurologists Should Know - Clinical Impact, Indicat…

Northwestern Medicine Neurology and Neurosurgery

I. Grant

Neuropsychological Assessment in Dementia Diagnosis

Northwestern Medicine Neurology and Neurosurgery

S. Weintraub

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Updates in Dementia

2023 Conference Coverage

P. Tipton

Preventing Cognitive Decline with Lithium

Psychiatry Redefined

J. Greenblatt

Alzheimer's: Clinical Pearls

Lawrence Robbins

Microbiome Screening in 2024: Ready For Prime Time?

Stanford Medicine

S. Spencer

Gut-Brain Axis & Migraine

Cleveland Clinic Neurological Institute

S. Biswas

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot